DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Dodick DW.
CGRP ligand and receptor monoclonal antibodies for migraine prevention: evidence review and clinical implications.
Cephalalgia 2019;
39 (03) 445-458
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.